SK

Sudha Kumari

Active Director Director DIN 08290968
DIN 08290968 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudha Kumari

Data last updated:

Sudha Kumari is a Director at Harrill Pharmaceutical Private Limited (since 2023) and Director at Phyllan Pharmaceutical Private Limited (since 2018). The companies operate in Pharma.

DIN 08290968
Primary Designation Director
Industry Pharma
First Appointment 29 Nov 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20232023Active
Director29 Nov 20182018Active

Board colleagues of Sudha Kumari

Directorship timeline

Open interactive timeline →
Phyllan Pharmaceutical Private Limited
Harrill Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sudha Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudha Kumari

Sudha Kumari currently holds 2 directorships: Harrill Pharmaceutical Private Limited (Director, since 05 Jan 2023); Phyllan Pharmaceutical Private Limited (Director, since 29 Nov 2018).

Sudha Kumari was first appointed on 29 Nov 2018 as Director at Phyllan Pharmaceutical Private Limited. The most recent appointment on record is 05 Jan 2023 at Harrill Pharmaceutical Private Limited.

The current boards of Sudha Kumari's companies include Munna Ram (Harrill Pharmaceutical Private Limited), Tanya Kaushik (Phyllan Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available